ArticleEJNMMI research2011

Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.

David Chatenet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.